CD274 and liver cancer: In addition, the combination of bispecific single domain antibody (BisCCL2/5i) and monoclonal antibody (PD-L1 inhibitor) enabled the mice to survive for a long time in liver metastasis models of the primary liver cancer, colorectal cancer, and pancreatic cancer [104].